The gut microbiota as a target for improved surgical outcome and improved patient care

Current Pharmaceutical Design

Volumn 15, Issue 13, 2009, Pages 1537-1545

  Kinross, James ^a   von Roon, Alexander C ^a   Penney, Nicholas ^a   Holmes, Elaine ^a   Silk, David ^a   Nicholson, Jeremy K ^a   Darzi, Ara ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Intestine; Metabonomics; Microbiome; Prebiotics; Probiotics; Sepsis; Surgery; Synbiotics

Indexed keywords

LACTOBACILLUS PLANTARUM 299V EXTRACT; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ACUTE PANCREATITIS; CLINICAL TRIAL; CRITICALLY ILL PATIENT; HUMAN; INTENSIVE CARE; INTESTINE FLORA; INTESTINE ISCHEMIA; METABOLOMICS; METAGENOMICS; MICROBIOME; MOLECULAR INTERACTION; MULTIPLE ORGAN FAILURE; NONHUMAN; OUTCOME ASSESSMENT; PATIENT CARE; PERIOPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEPSIS; SURGICAL INFECTION; SURGICAL INJURY; SYMBIOSIS; ANIMAL; GASTROINTESTINAL TRACT; GENOMICS; METHODOLOGY; MICROBIOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ANIMALS; GASTROINTESTINAL TRACT; GENOMICS; HUMANS; METABOLOMICS; MICROBIOME; MULTIPLE ORGAN FAILURE; PATIENT CARE; POSTOPERATIVE COMPLICATIONS; PROBIOTICS; SEPSIS; TREATMENT OUTCOME;

EID: 67650596799     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209788168119     Document Type: Review

References (99)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-54.
2. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10.
3. Angus DC, Wax RS. Epidemiology of sepsis: An update. Crit Care Med 2001; 29, S109-16.
4. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-50.
5. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31: 2332-8.
6. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006; 34: 344-53.
7. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
8. Alverdy JC, Laughlin RS, Wu L. Influence of the critically ill state on host-pathogen interactions within the intestine: Gut-derived sepsis redefined. Crit Care Med 2003; 31: 598-607.
9. Bucher P, Gervaz P, Soravia C, Mermillod B, Erne M, Morel P. Randomized clinical trial of mechanical bowel preparation versus no preparation before elective left-sided colorectal surgery. Br J Surg 2005; 92: 409-14.
10. Wren SM, Ahmed N, Jamal A, Safadi BY. Preoperative oral antibiotics in colorectal surgery increase the rate of Clostridium difficile colitis. Arch Surg 2005; 140: 752-6.
11. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV. Multipleorgan-failure syndrome. Arch Surg 1986; 121: 196-208.
12. Barie PS, Williams MD, McCollam JS, Bates BM, Qualy RL, Lowry SF, et al. Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 2004; 188: 212-20.
13. Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 1993; 218: 111-9.
14. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-11.
15. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983; 23: 775-87.
16. Goris RJ, Boekholtz WK, van Bebber IP, Nuytinck JK, Schillings PH Multiple-organ failure and sepsis without bacteria. An experimental model. Arch Surg 1986; 121: 897-901.
17. Chang TW. Improvement of survival from hemorrhagic shock by enterectomy in rats: Finding to implicate the role of the gut for irreversibility of hemorrhagic shock. J Trauma 1997; 42: 223-30.
18. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: What is important in human beings? Surgery 2002; 131: 241-4.
19. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci 1994; 307: 284-92.
20. Zimmerman BJ, Granger DN. Oxygen free radicals the gastrointestinal tract: Role in ischemia-reperfusion injury. Hepatogastroenterology 1994; 41: 337-42.
21. Haglund U. Gut ischaemia. Gut 1994; 35, S73-6.
22. Xing HC, Li LJ, Xu KJ, Shen T, Chen YB, Sheng JF, et al. Intestinal microflora in rats with ischemia/reperfusion liver injury. J Zhejiang Univ Sci B 2005; 6: 14-21.
23. Opal SM, Gluck T. Endotoxin as a drug target. Crit Care Med 2003; 31: S57-64.
24. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996; 20: 411-7.
25. Cicalese L, Billiar TR, Rao AS, Bauer AJ. Interaction between ischemia/ reperfusion-induced leukocyte emigration and translocating bacterial enterotoxins on enteric muscle function. Transplant Proc 1997; 29: 1815.
26. Turnage RH, Guice KS, Oldham KT. Endotoxemia and remote organ injury following intestinal reperfusion. J Surg Res 1994; 56: 571-8.
27. Nezu Y, Tagawa M, Sakaue Y, Hara Y, Tsuchida S, Ogawa R. Kinetics of endotoxin concentration and tumor necrosis factoralpha, interleukin-1beta, and interleukin-6 activities in the systemic and portal circulation during small intestinal ischemia and reperfusion in dogs. Am J Vet Res 2002; 63: 1680-6.
28. Souza DG, Vieira AT, Soares AC, Pinho V, Nicoli JR, Vieira LQ, et al. The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J Immunol 2004; 173: 4137-46.
29. Adams CA, Jr. Sambol JT Xu, DZ Lu, Q, Granger DN, Deitch EA. Hemorrhagic shock induced up-regulation of P-selectin expression is mediated by factors in mesenteric lymph and blunted by mesenteric lymph duct interruption. J Trauma 2001; 51: 625-631; discussion 631-22.
30. Adams JM, Hauser CJ, Adams CA, Jr., Xu DZ, Livingston DH, Deitch EA. Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. Crit Care Med 2001; 29: 2194-8.
31. Caruso JM, Feketeova E, Dayal SD, Hauser CJ, Deitch EA. Factors in intestinal lymph after shock increase neutrophil adhesion molecule expression and pulmonary leukosequestration. J Trauma 2003; 55: 727-33.
32. Magnotti LJ, Upperman JS, Xu, DZ, Lu Q, Deitch EA. Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 1998; 228: 518-27.
33. Reddy BS, MacFie J, Gatt M, Macfarlane-Smith L, Bitzopoulou K, Snelling AM. Commensal bacteria do translocate across the intestinal barrier in surgical patients. Clin Nutr 2007; 26: 208-15.
34. MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ. Bacterial translocation studied in 927 patients over 13 years. Br J Surg 2006; 93: 87-93.
35. Cruz N, Lu Q, Alvarez X, Deitch EA. Bacterial translocation is bacterial species dependent: Results using the human Caco-2 intestinal cell line. J Trauma 1994; 36: 612-6.
36. O'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC. Microbiology of bacterial translocation in humans. Gut 1998; 42: 29-35.
37. Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005; 128: 1258-67.
38. Nazli A, Yang PC, Jury J, Howe K, Watson JL, Soderholm JD, et al. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol 2004; 164: 947-57.
39. Spahn TW, Kucharzik T. Modulating the intestinal immune system: The role of lymphotoxin and GALT organs. Gut 2004; 53: 456-65.
40. Garside P, Millington O, Smith KM. The anatomy of mucosal immune responses. Ann NY Acad Sci 2004; 1029: 9-15.
41. Song F, Whitacre CC. The role of the gut lymphoid tissue in induction of oral tolerance. Curr Opin Investig Drugs 2001; 2: 1382-6.
42. Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma 2006; 60: 126-33.
43. Kelly D, Conway S, Aminov R. Commensal gut bacteria: Mechanisms of immune modulation. Trends Immunol 2005; 26: 326-33.
44. Alverdy JC, Chang EB. The re-emerging role of the intestinal microflora in critical illness and inflammation: Why the gut hypothesis of sepsis syndrome will not go away. J Leukoc Biol 2008; 83: 461-6.
45. Madara JL, Nash S, Moore R, Atisook K. Structure and function of the intestinal epithelial barrier in health and disease. Monogr Pathol 1990: 306-24.
46. Macpherson AJ, Geuking MB, McCoy KD. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 2005; 115: 153-62.
47. Schesser K, Spiik AK Dukuzumuremyi JM, Neurath MF, Pettersson S, Wolf-Watz H. The yopJ locus is required for Yersiniamediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 1998; 28: 1067-79.
48. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, et al. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 2000; 289: 1560-3.
49. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, et al. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005; 100: 2560-8.
50. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-41.
51. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-76.
52. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5: 104-12.
53. Reading NC, Sperandio V. Quorum sensing: The many languages of bacteria. FEMS Microbiol Lett 2006; 254: 1-11.
54. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB Bacteriahost communication: The language of hormones. Proc Natl Acad Sci USA 2003; 100: 8951-6.
55. Thanassi DG. Ushers and secretins: Channels for the secretion of folded proteins across the bacterial outer membrane. J Mol Microbiol Biotechnol 2002; 4: 11-20.
56. Tampakaki AP, Fadouloglou VE, Gazi AD, Panopoulos NJ, Kokkinidis M. Conserved features of type III secretion. Cell Microbiol 2004; 6: 805-16.
57. Wu L, Holbrook C, Zaborina O, Ploplys E, Rocha F, Pelham D, et al. Pseudomonas aeruginosa expresses a lethal virulence determinant, the PA-I lectin/adhesin, in the intestinal tract of a stressed host: The role of epithelia cell contact and molecules of the Quorum Sensing Signaling System. Ann Surg 2003; 238: 754-64.
58. Ramsay G, van Saene RH. Selective gut decontamination in intensive care and surgical practice: Where are we? World J Surg 1998; 22: 164-70.
59. Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, et al. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003; 299: 2074-76.
60. Narushima S, Itoha K, Miyamoto Y, Park SH, Nagata K, Kuruma K, et al. Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 2006; 41: 835-43.
61. Mai V. Dietary modification of the intestinal microbiota. Nutr Rev 2004; 62: 235-42.
62. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102: 11070-5.
63. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-31.
64. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nat 2006; 444: 1022-3.
65. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004; 28: 405-40.
66. Ouwehand AC, Salminen S, Isolauri E. Probiotics: An overview of beneficial effects. Antonie van Leeuwenhoek 2002; 82: 279-89.
67. Gill HS. Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res 2003; 17: 755-73.
68. Wold AE. Immune effects of probiotics. Scand J Nutr 2001; 45: 76-85.
69. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276: G941-50.
70. Falony G, Vlachou A, Verbrugghe K, De Vuyst L. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 2006; 72: 7835-41.
71. Suzuki T, Itoh K, Kaneko T, Suzuki H. Inhibition of bacterial translocation from the gastrointestinal tract of mice by oral administration of a culture condensate of Bifidobacterium longum. J Vet Med Sci/Japanese Soc Vet Sci 1997; 59: 665-9.
72. Bai AP, Ouyang Q, Xiao XR, Li SF. Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis. Int J clin Pract 2006; 60: 284-8.
73. Silk DB, Gow NM. Postoperative starvation after gastrointestinal surgery. Early feeding is beneficial. BMJ (Clinical Res ed 2001; 323: 761-2.
74. Bengmark S. Bioecologic control of the gastrointestinal tract: The role of flora and supplemented probiotics and synbiotics. Gastroenterol Clin North Am 2005; 34: 413-36, viii.
75. Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, et al. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003; 37: 105-18.
76. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995; 125: 1401-12.
77. Rayes N, Hansen S, Seehofer D, Muller AR, Serke S, Bengmark S, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: A controlled trial in patients with major abdominal surgery. Nutrition 2002; 18: 609-15.
78. McNaught CE, Woodcock NP, MacFie J, Mitchell CJ A. prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 2002; 51: 827-31.
79. Reddy BS, Macfie J, Gatt M, Larsen CN, Jensen SS, Leser TD. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007; 94: 546-54.
80. Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nussler NC, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: A randomized, double-blind trial. Ann Surg 2007; 246: 36-41.
81. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: A randomized controlled trial. Ann Surg 2006; 244: 706-14.
82. Kinross J, Warren O, Silk D, Darzi A. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: A randomized control trial. Ann Surg 2007; 245: 1000.
83. Watkinson PJ, Barber VS, Dark P, Young JD. The use of pre- pro- and synbiotics in adult intensive care unit patients: Systematic review. Clin Nutr 2007; 26: 182-92.
84. Alberda C, Gramlich L, Meddings J, Field C, McCargar L, Kutsogiannis D, et al. Effects of probiotic therapy in critically ill patients: A randomized, double-blind, placebo-controlled trial. Am J Clin Nut 2007; 85: 816-23.
85. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115: 178-81.
86. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89: 1103-7.
87. Olah A, Belagyi T, Poto L, Romics L, Jr., Bengmark S. Synbiotic control of inflammation and infection in severe acute pancreatitis: A prospective, randomized, double blind study. Hepatogastroenterology 2007; 54: 590-4.
88. Vogel G. Clinical trials. Deaths prompt a review of experimental probiotic therapy. Science 2008; 319: 557.
89. Rahman SH, Ammori BJ, Holmfield J, Larvin M, McMahon MJ. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg 2003; 7: 26-35; discussion 35-26.
90. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-9.
91. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica; Fate Foreign Comp Biolog Sys 1999; 29: 1181-9.
92. Nicholson JK, Holmes E, Lindon JC, Wilson ID. The challenges of modeling mammalian biocomplexity. Nat Biotechnol 2004; 22: 1268-74.
93. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002; 1: 153-61.
94. Saric J, Wang Y, Li J, Coen M, Utzinger J, Marchesi JR, et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res 2008; 7: 352-60.
95. Li M, Wang B, Zhang M, Rantalainen M, Wang S, Zhou H, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008; 105: 2117-22.
96. Martin FP, Wang Y, Sprenger N, Yap IK, Lundstedt T, Lek P, et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Sys Biol 2008; 4: 157.
97. Martin FP, Verdu EF, Wang Y, Dumas ME, Yap IK, Cloarec O, et al. Transgenomic metabolic interactions in a mouse disease model: interactions of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation. J Proteome Res 2006; 5: 2185-93.
98. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007; 6: 546-51.
99. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev 2005; 3: 431-8.